# Royal Gold Inc: financial statements, quarterly

RGLD · Nasdaq · CIK 85535 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rgld.md) · [Financials](/companies/rgld/financials.md) · [Filings](/companies/rgld/filings.md) · [Insiders](/companies/rgld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rgld/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [139](/filings/0000085535-24-000048.md) | [153 d](/filings/0000085535-26-000008.md) | [149](/filings/0000085535-25-000083.md) | [174](/filings/0000085535-25-000125.md) | [194](/filings/0000085535-25-000165.md) | [203 d](/filings/0000085535-26-000008.md) | [193](/filings/0000085535-26-000028.md) | [210](/filings/0000085535-26-000041.md) | [252](/filings/0000085535-25-000165.md) | [375 d](/filings/0000085535-26-000008.md) | [469](/filings/0000085535-26-000028.md) | [451](/filings/0000085535-26-000041.md) |
| Gross profit | $m | [75.6](/filings/0000085535-24-000048.md) | [89.5 d](/filings/0000085535-26-000008.md) | [87.0](/filings/0000085535-25-000083.md) | [113](/filings/0000085535-25-000125.md) | [129](/filings/0000085535-25-000165.md) | [142 d](/filings/0000085535-26-000008.md) | [134](/filings/0000085535-26-000028.md) | [152](/filings/0000085535-26-000041.md) | [185](/filings/0000085535-25-000165.md) | [242 d](/filings/0000085535-26-000008.md) | [315](/filings/0000085535-26-000028.md) | [291](/filings/0000085535-26-000041.md) |
| Operating income | $m | [65.6](/filings/0000085535-24-000048.md) | [79.7 d](/filings/0000085535-26-000008.md) | [75.5](/filings/0000085535-25-000083.md) | [102](/filings/0000085535-25-000125.md) | [119](/filings/0000085535-25-000165.md) | [133 d](/filings/0000085535-26-000008.md) | [123](/filings/0000085535-26-000028.md) | [142](/filings/0000085535-26-000041.md) | [162](/filings/0000085535-25-000165.md) | [211 d](/filings/0000085535-26-000008.md) | [297](/filings/0000085535-26-000028.md) | [280](/filings/0000085535-26-000041.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.8](/filings/0000085535-24-000048.md) | [13.4 d](/filings/0000085535-26-000008.md) | [27.0](/filings/0000085535-25-000083.md) | [19.0](/filings/0000085535-25-000125.md) | [21.5](/filings/0000085535-25-000165.md) | [26.1 d](/filings/0000085535-26-000008.md) | [10.4](/filings/0000085535-26-000028.md) | [10.5](/filings/0000085535-26-000041.md) | [28.7](/filings/0000085535-25-000165.md) | [52.7 d](/filings/0000085535-26-000008.md) | [25.4](/filings/0000085535-26-000028.md) | [58.2](/filings/0000085535-26-000041.md) |
| Net income | $m | [49.3](/filings/0000085535-24-000048.md) | [62.8 d](/filings/0000085535-26-000008.md) | [47.2](/filings/0000085535-25-000083.md) | [81.2](/filings/0000085535-25-000125.md) | [96.2](/filings/0000085535-25-000165.md) | [107 d](/filings/0000085535-26-000008.md) | [113](/filings/0000085535-26-000028.md) | [132](/filings/0000085535-26-000041.md) | [127](/filings/0000085535-25-000165.md) | [93.6 d](/filings/0000085535-26-000008.md) | [281](/filings/0000085535-26-000028.md) | [236](/filings/0000085535-26-000041.md) |
| Diluted EPS | $ per share | [0.75](/filings/0000085535-24-000048.md) | not reported | [0.72](/filings/0000085535-25-000083.md) | [1.23](/filings/0000085535-25-000125.md) | [1.46](/filings/0000085535-25-000165.md) | not reported | [1.72](/filings/0000085535-26-000028.md) | [2.01](/filings/0000085535-26-000041.md) | [1.92](/filings/0000085535-25-000165.md) | not reported | [3.30](/filings/0000085535-26-000028.md) | [2.78](/filings/0000085535-26-000041.md) |
| Basic EPS | $ per share | [0.75](/filings/0000085535-24-000048.md) | not reported | [0.72](/filings/0000085535-25-000083.md) | [1.23](/filings/0000085535-25-000125.md) | [1.46](/filings/0000085535-25-000165.md) | not reported | [1.72](/filings/0000085535-26-000028.md) | [2.01](/filings/0000085535-26-000041.md) | [1.92](/filings/0000085535-25-000165.md) | not reported | [3.31](/filings/0000085535-26-000028.md) | [2.78](/filings/0000085535-26-000041.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [103](/filings/0001558370-23-017277.md) | [104](/filings/0000085535-25-000012.md) | [138](/filings/0000085535-24-000010.md) | [74.2](/filings/0000085535-24-000029.md) | [128](/filings/0000085535-24-000048.md) | [195](/filings/0000085535-26-000008.md) | [241](/filings/0000085535-25-000083.md) | [248](/filings/0000085535-25-000125.md) | [173](/filings/0000085535-25-000165.md) | [234](/filings/0000085535-26-000041.md) | [234](/filings/0000085535-26-000028.md) | [182](/filings/0000085535-26-000041.md) |
| Current assets | $m | [164](/filings/0001558370-23-017277.md) | [167](/filings/0000085535-25-000012.md) | [193](/filings/0000085535-24-000010.md) | [133](/filings/0000085535-24-000029.md) | [202](/filings/0000085535-24-000048.md) | [275](/filings/0000085535-26-000008.md) | [316](/filings/0000085535-25-000083.md) | [342](/filings/0000085535-25-000125.md) | [287](/filings/0000085535-25-000165.md) | [377](/filings/0000085535-26-000041.md) | [412](/filings/0000085535-26-000028.md) | [370](/filings/0000085535-26-000041.md) |
| Total assets | $m | [3,397](/filings/0001558370-23-017277.md) | [3,361](/filings/0000085535-25-000012.md) | [3,313](/filings/0000085535-24-000010.md) | [3,269](/filings/0000085535-24-000029.md) | [3,302](/filings/0000085535-24-000048.md) | [3,392](/filings/0000085535-26-000008.md) | [3,458](/filings/0000085535-25-000083.md) | [3,572](/filings/0000085535-25-000125.md) | [4,465](/filings/0000085535-25-000165.md) | [9,538](/filings/0000085535-26-000041.md) | [9,490](/filings/0000085535-26-000028.md) | [9,449](/filings/0000085535-26-000041.md) |
| Current liabilities | $m | [70.8](/filings/0001558370-23-017277.md) | [72.4](/filings/0000085535-25-000012.md) | [77.1](/filings/0000085535-24-000010.md) | [122](/filings/0000085535-24-000029.md) | [86.3](/filings/0000085535-24-000048.md) | [85.2](/filings/0000085535-26-000008.md) | [66.8](/filings/0000085535-25-000083.md) | [76.1](/filings/0000085535-25-000125.md) | [99.5](/filings/0000085535-25-000165.md) | [121](/filings/0000085535-26-000041.md) | [117](/filings/0000085535-26-000028.md) | [127](/filings/0000085535-26-000041.md) |
| Total liabilities | $m | [535](/filings/0001558370-23-017277.md) | [460](/filings/0000085535-25-000012.md) | [390](/filings/0000085535-24-000010.md) | [288](/filings/0000085535-24-000029.md) | [251](/filings/0000085535-24-000048.md) | [261](/filings/0000085535-26-000008.md) | [243](/filings/0000085535-25-000083.md) | [253](/filings/0000085535-25-000125.md) | [1,049](/filings/0000085535-25-000165.md) | [2,332](/filings/0000085535-26-000041.md) | [2,027](/filings/0000085535-26-000028.md) | [1,816](/filings/0000085535-26-000041.md) |
| Long-term debt | $m | [321](/filings/0001558370-23-017277.md) | [246](/filings/0000085535-25-000012.md) | [146](/filings/0000085535-24-000010.md) | [0.0](/filings/0000085535-24-000029.md) | [0.0](/filings/0000085535-24-000048.md) | [0.0](/filings/0000085535-26-000008.md) | not reported | not reported | [770](/filings/0000085535-25-000165.md) | [895](/filings/0000085535-26-000041.md) | [596](/filings/0000085535-26-000028.md) | [396](/filings/0000085535-26-000041.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0000085535-24-000029.md) | not reported | [50.0](/filings/0000085535-24-000029.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,849](/filings/0001558370-23-017277.md) | [2,888](/filings/0000085535-25-000012.md) | [2,911](/filings/0000085535-24-000010.md) | [2,969](/filings/0000085535-24-000029.md) | [3,039](/filings/0000085535-24-000048.md) | [3,119](/filings/0000085535-26-000008.md) | [3,203](/filings/0000085535-25-000083.md) | [3,307](/filings/0000085535-25-000125.md) | [3,406](/filings/0000085535-25-000165.md) | [7,157](/filings/0000085535-26-000041.md) | [7,415](/filings/0000085535-26-000028.md) | [7,587](/filings/0000085535-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [98.1 d](/filings/0000085535-24-000048.md) | [101 d](/filings/0000085535-26-000008.md) | [138](/filings/0000085535-25-000083.md) | [114 d](/filings/0000085535-25-000125.md) | [137 d](/filings/0000085535-25-000165.md) | [141 d](/filings/0000085535-26-000008.md) | [136](/filings/0000085535-26-000028.md) | [153 d](/filings/0000085535-26-000041.md) | [174 d](/filings/0000085535-25-000165.md) | [242 d](/filings/0000085535-26-000008.md) | [294](/filings/0000085535-26-000028.md) | [335 d](/filings/0000085535-26-000041.md) |
| Dividends paid | $m | [24.6 d](/filings/0000085535-24-000048.md) | [24.6 d](/filings/0000085535-26-000008.md) | [26.3](/filings/0000085535-25-000083.md) | [26.3 d](/filings/0000085535-25-000125.md) | [26.3 d](/filings/0000085535-25-000165.md) | [26.3 d](/filings/0000085535-26-000008.md) | [29.6](/filings/0000085535-26-000028.md) | [29.6 d](/filings/0000085535-26-000041.md) | [29.6 d](/filings/0000085535-25-000165.md) | [29.6 d](/filings/0000085535-26-000008.md) | [40.2](/filings/0000085535-26-000028.md) | [40.3 d](/filings/0000085535-26-000041.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [30.0](/filings/0000085535-26-000041.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [65.7](/filings/0001558370-23-017277.md) | [65.7](/filings/0000085535-24-000010.md) | [65.8](/filings/0000085535-24-000029.md) | [65.8](/filings/0000085535-24-000048.md) | [65.7](/filings/0000085535-25-000083.md) | [65.8](/filings/0000085535-25-000125.md) | [65.8](/filings/0000085535-25-000165.md) | [65.8](/filings/0000085535-26-000028.md) | [65.8](/filings/0000085535-26-000041.md) | [65.8](/filings/0000085535-25-000165.md) | [85.0](/filings/0000085535-26-000028.md) | [85.1](/filings/0000085535-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 84,727,857 at 2026-07-29, from the cover of the [10-Q filed 2026-08-06](/filings/0000085535-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.